European Union Regulator Says Benefits Outweigh Risks Of Johnson & Johnson Vaccine

The European Medicines Agency says there is a possible link between the J&J vaccine and rare blood clotting. It says a warning should be added to the label, but says benefits outweigh the risks.
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news